It is proposed the new preparation tiotriazolini for treatment of diabetic rethinopathy. The carried out researches revealed its high efficacy, which manifests itself in acuity of vision in 83.8 % of patients, prevention of complication and recurrence consequences. Before treatment average visual acuity was 0.35±0.07, after treatment — 0.65±0.03.
